IC

Indogulf Cropsci

Q4 FY26Fertilizers & Agrochemicals

Indogulf Cropsci Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹72
Market cap₹460 Cr
P/E12.0
Updated25 Aug 2026
Read5 min read

The short version

The company aims for strong growth with plans to reach INR 1,500-1,600 crores revenue in the next 2-3 years, supported by expanded manufacturing capacity (INR 1,600-1,800 crores potential from new plant). The company expects steady growth driven by high-margin products, demand generation, and deeper rural penetration via subsidiary AbhiPrakash Globus Pvt Ltd.

From Indogulf Cropsci's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

  • The company aims for strong growth with plans to reach INR 1,500-1,600 crores revenue in the next 2-3 years, supported by expanded manufacturing capacity (INR 1,600-1,800 crores potential from new plant).
  • Specialty products are expected to grow, with new launches planned in nutrients, herbicides, and fungicides boosting portfolio differentiation.
  • Biologicals and plant nutrients currently at 11% revenue mix will grow in absolute terms with high margins but are expected to remain around the same percentage.
  • Exports will remain a significant growth driver, with expansion into new markets like Venezuela, Taiwan, and Sri Lanka.
  • The integrated agri-solutions approach and deeper farmer engagement aim to sustain continuous demand across crop cycles.

2 more points from Indogulf Cropsci's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Indogulf Cropsci said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Indogulf Cropsciences is expanding its Barwasni facility capacity by approximately 30%-40%, expected to be operational by the end of FY27.
  • The expansion includes compliance and licensing processes involving the Central Insecticide Board, state authorities, fertilizer licenses, and pollution clearances.
  • Capex till date is around INR 76 crores, with an additional INR 8-10 crores planned.
  • The new plant’s capacity can support revenues up to INR 1,600-1,800 crores, sufficient for the next 3-4 years of expansion.
  • The expansion mainly focuses on warehousing raw materials and finished goods to reduce inventory days and improve on-time inventory preparation.
  • Indogulf intends to invest in automation and process optimization to improve manufacturing efficiency.

2 more points from Indogulf Cropsci's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Indogulf Cropsci said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Indogulf Cropsciences Limited. However, some related points include: - Successful single order in Venezuela contributing approximately INR 4 crores in revenue, indicating active export orders. - The company is gearing up with sufficient inventory for Q1 FY27, reflecting preparedness for upcoming demand. - Expansion in multiple domestic states and entering new international markets like Taiwan and Sudan (though Sudan has had limited success so far).

2 more points from Indogulf Cropsci's call on order book

Pro opens every point from 15K+ earnings calls

Indogulf Cropsci — Quarterly revenue & net profit

Revenue Net profit
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹109 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Dhansa Labs Ltd (Q4 FY26)

    120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…

  • Advance Agrolife Ltd (Q4 FY26)

    Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…

  • Bhagiradha Chemicals & Industries Ltd (Q4 FY26)

    158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Punjab Chemicals & Crop Protection Ltd (Q4 FY26)

    Overall volume growth in FY '26 was around 14%, primarily driven by new products. Key concall takeaways from Punjab Chemicals & Crop Protection Ltd's Q4 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Indogulf Cropsci and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Indogulf Cropsci Q4 FY26 results?

The company aims for strong growth with plans to reach INR 1,500-1,600 crores revenue in the next 2-3 years, supported by expanded manufacturing capacity (INR 1,600-1,800 crores potential from new plant). The company expects steady growth driven by high-margin products, demand generation, and deeper rural penetration via subsidiary AbhiPrakash Globus Pvt Ltd.

What is Indogulf Cropsci share price analysis?

Indogulf Cropsci currently shows a neutral. The stock trades at a P/E of 11.9 with a market cap of ₹460 Cr. Investors should review the full earnings analysis for detailed insights.

Is Indogulf Cropsci planning capital expenditure?

Indogulf Cropsciences is expanding its Barwasni facility capacity by approximately 30%-40%, expected to be operational by the end of FY27.

Keep Indogulf Cropsci on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.